|
SNAPIN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.569200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.084800E-01 |
| Normal-vs-Stage2 |
7.350400E-01 |
| Normal-vs-Stage3 |
1.558990E-01 |
| Normal-vs-Stage4 |
3.823800E-01 |
| Stage1-vs-Stage2 |
8.421400E-01 |
| Stage1-vs-Stage3 |
9.186000E-02 |
| Stage1-vs-Stage4 |
4.147800E-01 |
| Stage2-vs-Stage3 |
3.905600E-01 |
| Stage2-vs-Stage4 |
7.322400E-01 |
| Stage3-vs-Stage4 |
5.061000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.479400E-01 |
| Normal-vs-AfricanAmerican |
8.052200E-01 |
| Normal-vs-Asian |
6.603400E-01 |
| Caucasian-vs-AfricanAmerican |
2.465000E-01 |
| Caucasian-vs-Asian |
5.387000E-01 |
| AfricanAmerican-vs-Asian |
7.050800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.139600E-01 |
| Normal-vs-Female |
8.751600E-01 |
| Male-vs-Female |
2.149600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.974400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.981600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.557400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.803600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.970000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.680600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.119800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.947800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.292600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.704970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.846400E-02 |
| Normal-vs-Grade 2 |
8.568800E-01 |
| Normal-vs-Grade 3 |
2.041600E-01 |
| Normal-vs-Grade 4 |
2.955400E-01 |
| Grade 1-vs-Grade 2 |
3.132200E-02 |
| Grade 1-vs-Grade 3 |
1.125720E-02 |
| Grade 1-vs-Grade 4 |
5.982600E-03 |
| Grade 2-vs-Grade 3 |
1.024420E-01 |
| Grade 2-vs-Grade 4 |
2.611000E-01 |
| Grade 3-vs-Grade 4 |
9.030400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.135000E-01 |
| Normal-vs-ccB subtype |
2.391400E-01 |
| ccA subtype-vs-ccB subtype |
1.544390E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.029000E-01 |
| Normal-vs-N1 |
4.879600E-01 |
| N0-vs-N1 |
1.879400E-01 |
|
|
